- Tytuł :
- Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
- Autorzy :
- Źródło :
- In The Lancet Respiratory Medicine May 2020 8(5):453-460
-
Czasopismo naukowe